U.S. Pharma Stock News

Recent price moves and business snapshot Andersen Group (ANDG) has seen mixed short term price moves, with a 2.4% decline over the past day, alongside gains of 22.2% over the week and 28.2% over the past month. The company provides independent tax, valuation, and financial advisory services across private clients, businesses, alternative investment funds, and institutional investors in the United States. It reported revenue of US$838.692m and a net loss of US$2.324m. See our latest analysis...

What the Emburse and DocuSign expansions mean for Dayforce stock Dayforce (DAY) has broadened its relationships with Emburse and DocuSign, folding expense management and digital agreement tools more tightly into its HCM platform through certified integrations and a reseller model. For you as an investor, this move centers on two practical ideas: Dayforce aiming to keep more of a customer’s HR workflow inside its own ecosystem, and partners gaining distribution through Dayforce’s channel. See...

Shareholders at Dominion Energy (NYSE:D) have filed several proposals ahead of the upcoming annual meeting focused on board independence and governance reforms. Key items include calls to separate the CEO and Chair roles, tie executive pay to ESG and DEI metrics, and expand mechanisms for shareholder engagement. The company has recommended that investors vote against these proposals, setting up a clear point of tension between management and some shareholder groups. Dominion Energy, a major...

If you are wondering whether CoStar Group at US$42.90 is starting to look interesting on price alone, the recent share performance gives plenty to think about. The stock has declined 1.7% over the past week, 14.0% over the past month, and is down 34.7% year to date and 45.3% over the last year, which may suggest that the market is reassessing its expectations and risk appetite around the company. These moves sit against a backdrop where investors have been reacting to ongoing sector...

Interest in Humacyte (HUMA) is being shaped by a US$1.475 million minimum purchase commitment for Symvess in Saudi Arabia, along with a Marketing Authorization Application in Israel, both focused on vascular trauma treatment. See our latest analysis for Humacyte. The recent Saudi Arabia purchase commitment and Israel filing come at a time when Humacyte's share price return has moved sharply, with a 7 day share price return of 32.51% and a 1 year total shareholder return of 76.42%, suggesting...

Baidu (NasdaqGS:BIDU) announced the resignation of Mr. James Ding as an independent director. Mr. Ding also stepped down as chairman of Baidu's compensation committee. The change affects the composition and leadership of Baidu's board-level oversight. Baidu operates as a major internet and AI company in China, with businesses that span search, online marketing and cloud services. For investors, board composition matters because it shapes how executive pay, risk controls and long term...

Grupo Aeroméxico (NYSE:AERO) has filed a substantial shelf registration tied to an employee stock ownership plan. The registration relates to future issuance of shares to employees under the ESOP framework. The move signals a fresh phase in the company’s capital planning and workforce incentive approach. Grupo Aeroméxico, listed as NYSE:AERO, operates as Mexico’s flagship airline with a focus on passenger and cargo services. The new ESOP related shelf registration arrives at a time when...

If you are wondering whether Pharvaris at around US$26 a share still offers value, it helps to step back and look at what the recent returns and current valuation are really telling you. The stock has delivered a 68.8% return over the past year and a very large 3 year gain of around 3.5x, even though the year to date return is a 1.8% decline and the 30 day return is a 7.5% decline. This can change how the risk and reward balance feels right now. Recent headlines around Pharvaris have focused...

Coastal Financial (NasdaqGS:CCB) has appointed Jeffrey M. Chapman, a banking technology veteran with over 25 years of experience, to its Board of Directors. Chapman will serve on the Technology and CCBX Oversight Committees, with the appointment highlighting a focus on digital banking and platform development. Coastal Financial, trading at $74.36, has seen a mixed share price record, with a 103.6% return over 3 years and a 176.9% return over 5 years, alongside a 34.4% decline year to date...

In 2025, GEO Group reported a 16.5% year-on-year revenue increase that topped analyst expectations by 5.8% and secured new or expanded contracts expected to contribute about US$520.00 million in annualized revenues, making it the strongest year for new business wins in the company’s history. This combination of accelerating revenue and record contract activity contrasts with GEO Group’s more muted longer-term sales trends and rising cost pressures, highlighting a potential turning point in...

Clear Channel Outdoor’s Airports Division recently secured a new 10‑year contract with the Omaha Airport Authority to continue providing advertising at Omaha Eppley Airfield, backed by a US$1,000,000 investment in a modern, integrated media program targeting more than 5.2 million annual passengers. The contract highlights how upgraded digital displays, sponsorships, and local business partnerships could deepen Clear Channel Outdoor’s presence in airport advertising and support its broader...

Dorian LPG Ltd. has taken delivery of the 93,000 cubic meter dual-fuel very large gas carrier "Areion" from Hanwha Ocean Heavy Industries in South Korea, which will operate under the Helios LPG Pool jointly controlled with MOL Energia Pte Ltd. The addition of "Areion" underscores DorianG's push toward advanced, lower-emission propulsion and ammonia-ready capacity, potentially strengthening its positioning in cleaner gas shipping solutions. We will now examine how adding the dual-fuel...

Wondering if AppLovin's current share price reflects its true worth, or if the market is mispricing the story. The stock recently closed at US$442.39, with returns of 5.7% over 30 days, a 28.5% decline year to date, and 40.9% over the last year, alongside a very large 3 year return. Recent coverage has focused on AppLovin's position within software and digital advertising, as investors reassess how its platform fits into the broader app monetization ecosystem. That context helps explain why...

SWK Holdings (SWKH) closed out FY 2025 with fourth quarter revenue of US$6.6 million and a basic EPS loss of US$1.60, compared with revenue of US$9.2 million and basic EPS of US$0.48 in the same quarter a year earlier. The trailing twelve month EPS came in at a loss of US$0.21 on revenue of US$37.6 million. Over recent quarters, revenue has moved from US$9.2 million in Q4 2024 to US$12.2 million in Q1 2025, US$8.1 million in Q2 2025 and US$10.6 million in Q3 2025. Basic EPS shifted from...

Wondering whether GeneDx Holdings at around US$69.84 is a bargain or already pricing in a lot of optimism? This article walks through what the numbers currently say about value. The stock has had a choppy run, with a 10.2% decline over the last 7 days, a 14.9% decline over the last 30 days, a 47.2% decline year to date, a very large 3 year return, and a 33.1% decline over the last year. These swings have kept GeneDx on the radar for investors watching for changing expectations and risk...

Event context and recent share performance Merit Medical Systems (MMSI) shares have come under pressure recently, with the stock showing a 2.4% decline over the past day, 4.6% over the past week, and deeper pullbacks over the past month and past 3 months. See our latest analysis for Merit Medical Systems. The recent pullback, including a 30 day share price return of 18.9% decline and a year to date share price return of 22.8% decline, sits alongside a 1 year total shareholder return of 34.4%...

Opera (NasdaqGS:OPRA) and Celo have agreed a restructured, multi year partnership that makes Opera a major network stakeholder in the Celo ecosystem. The deal centers on MiniPay and a planned push to drive global stablecoin usage across up to 50 million Opera users. The partnership includes a 160 million CELO allocation, expansion of MiniPay into new markets, and grassroots roadshows to support user adoption. Opera, trading at $14.36, now ties a bigger part of its fintech plans to the Celo...

Wondering if Hess Midstream at around US$39.59 is still offering value, or if most of the easy gains are already on the table. The stock has returned 1.5% over the last 7 days, 4.5% over the last 30 days, 14.3% year to date and 0.4% over the past year, with very large returns over the past 3 and 5 years of 85.1% and 173.4% respectively. Recent coverage has focused on Hess Midstream's role as a midstream infrastructure provider and how that positions the company within the broader energy...

Wondering if Innospec, at around its recent US$65.89 close, is offering value or a value trap? This review breaks down what the current share price really reflects. The stock has recently seen a 4% decline over the past week, an 18.9% decline over the past month, and a 29.9% decline over the last year, which may signal that the market is reassessing both growth potential and risk. Recent coverage of Innospec has focused on its position within the chemicals sector and how investors are...

TransUnion (NYSE:TRU) has rolled out new machine learning capabilities within its Device Risk fraud prevention solution. The update targets recent surges in digital fraud and suspected account takeovers, aiming to improve detection accuracy and reduce manual review work for clients. The company is highlighting adaptive, consortium driven risk scoring as a way to respond to more complex fraud patterns in digital channels. TransUnion enters this product update phase with its shares at $70.55...

In March 2026, AEye, Inc. announced it had joined the ANAB-accredited NVIDIA Halos AI Systems Inspection Lab to collaborate on validating safety, cybersecurity, and system integration of its Apollo, STRATOS, and OPTIS lidar solutions with NVIDIA DRIVE platforms. On the same day, AEye reported fourth-quarter 2025 sales of US$97,000 and a net loss of US$7.34 million, with full-year 2025 sales of US$233,000 and a net loss of US$33.96 million, showing modest revenue progress alongside continued...

If you are wondering whether FormFactor's current share price lines up with its underlying worth, this article will walk you through what the numbers are actually saying. The stock recently closed at US$92.22, with returns of 2.6% over 7 days, a 2.5% decline over 30 days, 55.8% year to date and 196.4% over 1 year that may catch your eye. Recent coverage has focused on FormFactor as a semiconductor testing specialist, with investors watching how its technology and customer exposure position...

TG Therapeutics, ticker NasdaqCM:TGTX, announced a new five year, $750 million senior secured credit facility with Blue Owl Capital. The agreement is described as non dilutive, meaning it does not involve issuing new equity to raise capital. The facility includes repayment of prior debt and could expand to as much as $1b in total available financing. TG Therapeutics focuses on developing and commercializing therapies in the biopharmaceutical space, where access to sizeable, flexible capital...

Investors may be wondering whether Progress Software's current share price reflects its true value, or if the recent weakness is opening up an opportunity. The stock closed at US$31.29, with returns of an 8.8% decline over 7 days, a 22.4% decline over 30 days, a 23.8% decline year to date, and a 42.5% decline over 1 year. These moves may have shifted how the market views its risk and reward trade off. Recent headlines have focused on Progress Software's role as a software provider and how...